UFDI Researcher Patrick Concannon, Ph.D. and collaborators found evidence that suggests that a small set of regulatory elements specify the regulatory T cell (Treg) lineage and that genetic variation in Treg cell-specific enhancers may alter Treg cell function contributing to polygenic disease.
UFDI researcher Patrick Concannon, Ph.D. and other collaborators found that four loci were associated with autoantibody positivity at genome-wide significance in type 1 diabetes.
UFDI Investigator Patrick Concannon, Ph.D. UFDI Investigator Patrick Concannon, Ph.D. and University of Virginia School of Medicine Investigator Stephen S. Rich recently published two papers on their findings from the Type 1 Diabetes Genetics Consortium (T1DGC). Summary of the Type…
Researchers include Benjamin M. Looney, Ph.D., Chang Qing Xia, M.D., Ph.D., Patrick Concannon, Ph.D., David Ostrov, Ph.D. and Michael J. Clare-Salzler, M.D.
UF genetics expert Patrick Concannon, Ph.D., is part of group that has homed in on the genes suspected in Type 1 diabetes. “It’s a game-changer,” he said.
See the latest online issue of UF Explore magazine for an in-depth profile of Pat Concannon, PhD, director of the UF Genetics Institute. Concannon's research focuses on autoimmune diseases, particularly type 1 diabetes; pages 22-27.
Four distinguished UF Health diabetes experts will be heading 'Down Under' to Australia during the first week of December to highlight Type 1 diabetes (T1D) research work at the 13th International Congress of the Immunology Diabetes Society (IDS) in Lorne, Australia.
Patrick J. Concannon, PhD, will serve as the next Director of the University of Florida Genetics Institute. Previously, Dr. Concannon served as Professor of Biochemistry and and Molecular Genetics at the University of Virginia School of Medicine. His research interests include cellular DNA damage responses, breast cancer genetics, and genetics of type 1 diabetes.
